Mia's Feed
Medical News & Research

How Vaping Weakens Lung Defenses Against COVID-19 Damage

How Vaping Weakens Lung Defenses Against COVID-19 Damage

Share this article

Vaping damages the delicate blood–air barrier in the lungs, increasing vulnerability to COVID-19 infection and worsening respiratory outcomes. Learn how quitting vaping can protect your lung health.

2 min read

As the colder months arrive, respiratory infections such as the common cold, flu, and COVID-19 tend to become more prevalent. Protecting lung health during this time is crucial, but habits like vaping can compromise lung tissue, making the body more vulnerable to these infections. Unlike the simplistic view of the lungs as two balloons, they are intricate organs responsible for a vital gas exchange process. The alveoli, tiny air sacs in the lungs, are separated from dense networks of blood vessels by the blood–air barrier. This barrier must be resilient yet flexible to facilitate efficient oxygen intake and carbon dioxide removal, challenging its integrity against environmental stressors like air pollution and microbes.

Vaping introduces a cocktail of chemicals into the lungs, including solvents like propylene glycol, flavoring agents, nicotine, and trace metals from the device. Once inhaled, these substances penetrate beyond the surface, irritating the endothelium—the thin layer of cells lining blood vessels that interface with alveoli. Healthy endothelium is essential for smooth blood flow, preventing clotting, and regulating substance exchange between blood and tissue. Studies have shown that vaping causes endothelial dysfunction, even in young and healthy individuals, by releasing tiny cell fragments called microparticles indicative of vessel stress.

Vaping aerosols can loosen the tight seal of pulmonary endothelial cells, leading to leaks that disrupt blood–gas exchange and predispose the lungs to infections. COVID-19 primarily impacts the vascular system, causing injuries such as inflammation, leaky capillaries, and clot formation, which can result in dangerously low oxygen levels even if the lungs appear unaffected. The virus exploits the ACE2 protein to invade cells, and smoking/vaping can increase the number of ACE2 receptors in the lungs, creating more entry points for the virus.

The combination of vaping and COVID-19 exacerbates inflammation and vascular damage, forming a dangerous synergy. Both stress the blood–air barrier, making it more prone to leaks, fluid accumulation, and clots, ultimately hindering oxygen transfer and recovery. Vaping also hampers the healing process by weakening the lung's delicate exchange surface, leading to prolonged symptoms, fatigue, and slower recovery. Quitting vaping, even temporarily, can help restore vascular health, support lung recovery, and reduce the severity and duration of COVID-19 symptoms.

In summary, vaping undermines lung and vascular function, increasing susceptibility to COVID-19 complications. Protecting your respiratory health through cessation efforts can significantly improve your body's ability to fight infections and recover more effectively.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Research Unveils Molecular Signatures Differentiating Depression and Schizophrenia in Blood

Scientists have identified specific blood lipid biomarkers that can accurately distinguish between depression and schizophrenia, paving the way for objective mental health diagnostics using blood tests.

New Insights into How Baby Nose Gene Activity Is Linked to Wheezing Illnesses

New research links gene activity in babies' noses to an increased risk of wheezing illnesses, offering potential for early diagnosis and prevention strategies in respiratory health.

Revolutionary Robot-Assisted Bronchoscopy Enhances Diagnosis of Tiny Lung Tumors

A new robotic-guided bronchoscopy with Cone-Beam CT significantly improves detection and biopsy of tiny, hard-to-reach lung tumors, enhancing early lung cancer diagnosis.